Literature DB >> 20532535

Mucinous adenocarcinoma showing different clinicopathological and molecular characteristics in relation to different colorectal cancer subgroups.

J M Chiang1, C Y Yeh, C R Changchien, J S Chen, R Tang, J R Chen.   

Abstract

BACKGROUND: Mucinous adenocarcinoma (MAC) is frequently reported to be associated with patients of young-age sporadic colorectal cancer (YSCC) and hereditary nonpolyposis colorectal cancer (HNPCC). This study is aimed to investigate whether the clinicopathological characteristics of MAC of HNPCC patients are distinct from those of YSCC patients. PATIENTS AND METHODS: Eighty-two HNPCC and 68 YSCC patients recorded in the colorectal cancer registry of Chang Gung Memorial Hospital at Linkou, Taiwan, between January 1, 1995 and December 31, 2001 were included in this study. Clinicopathological and molecular variables of MAC and non-MAC of HNPCC and YSCC patients were compared accordingly.
RESULTS: Compared to non-MAC, MAC significantly showed higher frequencies of poor differentiation (32% vs. 8.2%, p = 0.001), advanced tumor stage (76% vs. 47%, p = 0.002), loss of mismatch repair protein (MMR) expression (74% vs. 44%, p = 0.023), and increased MUC2 expression (98% vs. 61%, p < 0.001). MAC of HNPCC patients showed predominant right-sided colon involvement, whereas MAC of YSCC patients displayed predominance in the left colon (79% vs. 22%, p = 0.001). Among the non-MAC counterparts, more differences were detectable including tumor stage, loss of MMR expression, and increased MUC1 expression. Furthermore, both MAC and non-MAC of YSCC patients showed higher frequencies of advanced tumor stage (81% vs. 62%, p = 0.072). In contrast, the incidence of loss of MMR expression in MAC and non-MAC of HNPCC patients is not significantly different (86% vs. 70%, p = 0.323).
CONCLUSIONS: Significantly different tumor localization was observed between mucinous YSCC (left colon predominance) and mucinous HNPCC (right colon predominance).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532535     DOI: 10.1007/s00384-010-0958-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  21 in total

1.  Mismatch repair protein expression in Amsterdam II criteria-positive patients in Taiwan.

Authors:  J R Chen; J M Chiang; C R Changchien; J S Chen; R P Tang; J Y Wang
Journal:  Br J Surg       Date:  2008-01       Impact factor: 6.939

Review 2.  MUC1 and colorectal cancer pathophysiology considerations.

Authors:  Yaron Niv
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

3.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

Review 4.  Distinguishing benign dissecting mucin (stromal mucin pools) from invasive mucinous carcinoma.

Authors:  Diana Molavi; Pedram Argani
Journal:  Adv Anat Pathol       Date:  2008-01       Impact factor: 3.875

5.  Survival of patients diagnosed with either colorectal mucinous or non-mucinous adenocarcinoma: a population-based study in Canada.

Authors:  Lin Xie; Paul J Villeneuve; Amanda Shaw
Journal:  Int J Oncol       Date:  2009-04       Impact factor: 5.650

Review 6.  Mucins and mucin binding proteins in colorectal cancer.

Authors:  James C Byrd; Robert S Bresalier
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

7.  Genetic instability occurs in the majority of young patients with colorectal cancer.

Authors:  B Liu; S M Farrington; G M Petersen; S R Hamilton; R Parsons; N Papadopoulos; T Fujiwara; J Jen; K W Kinzler; A H Wyllie; B Vogelstein; M G Dunlop
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

8.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

9.  Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

Authors:  Y Hiraga; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto; N Kohno
Journal:  Oncology       Date:  1998 Jul-Aug       Impact factor: 2.935

Review 10.  Is mucinous carcinoma of the colorectum a distinct genetic entity?

Authors:  C Hanski
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

View more
  16 in total

1.  A case of colonic mucinous adenocarcinoma in 19-year-old male patient.

Authors:  Mi Yeon Chung; Young Sook Park; Sang Ryul Ryu; Sang Bong Ahn; Seong Hwan Kim; Yun Ju Jo; Jun Kil Han; Jong Eun Joo
Journal:  Clin Endosc       Date:  2012-03-31

2.  Poor prognosis of young patients with colorectal cancer: a retrospective study.

Authors:  Liying Zhao; Feng Bao; Jun Yan; Hao Liu; Tingting Li; Hao Chen; Guoxin Li
Journal:  Int J Colorectal Dis       Date:  2017-04-07       Impact factor: 2.571

Review 3.  Sporadic carcinoma of the colon-rectum in young patients: a distinct disease? A critical review.

Authors:  Andrea Ciarrocchi; Gianfranco Amicucci
Journal:  J Gastrointest Cancer       Date:  2013-09

4.  The Prognostic Implications of FIX and FLO Patterns in Mucinous Colon Carcinomas.

Authors:  Sulen Sarioglu; Guray Akturk; Selman Sokmen; Hulya Ellidokuz; Aras Emre Canda; Mehtat Unlu; Abdullah Haluk Sirin; Ozgul Sagol; Cem Terzi; Mehmet Fuzun
Journal:  J Gastrointest Cancer       Date:  2019-06

5.  Clinicopathological Significance of Mucin 2 Immuno-histochemical Expression in Colorectal Cancer: A Meta-Analysis.

Authors:  Li Li; Pei-Lin Huang; Xiao-Jin Yu; Xiao-Dong Bu
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

6.  Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy.

Authors:  Kensuke Kaneko; Kazushige Kawai; Shinsuke Kazama; Koji Murono; Kazuhito Sasaki; Koji Yasuda; Kensuke Ohtani; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Hiroaki Nozawa; Soichiro Ishihara; Teppei Morikawa; Masashi Fukayama; Toshiaki Watanabe
Journal:  Surg Today       Date:  2016-09-22       Impact factor: 2.549

7.  Mismatch repair deficiency as a prognostic factor in mucinous colorectal cancer.

Authors:  Juliana Andrici; Mahtab Farzin; Loretta Sioson; Adele Clarkson; Nicole Watson; Christopher W Toon; Anthony J Gill
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

8.  The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer.

Authors:  Diana L Esposito; Federica Aru; Rossano Lattanzio; Annalisa Morgano; Michela Abbondanza; Reza Malekzadeh; Faraz Bishehsari; Rosa Valanzano; Antonio Russo; Mauro Piantelli; Antonio Moschetta; Lavinia Vittoria Lotti; Renato Mariani-Costantini
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  A case of mucinous adenocarcinoma in the setting of chronic colitis associated with intestinal spirochetosis and intestinal stricture.

Authors:  Shintaro Akiyama; Daisuke Kikuchi; Toshifumi Mitani; Takeshi Fujii; Akihiro Yamada; Akira Matsui; Osamu Ogawa; Toshiro Iizuka; Shu Hoteya; Mitsuru Kaise
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

10.  Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas: A Strobe-Compliant Study.

Authors:  Mo-Jin Wang; Jie Ping; Yuan Li; Annica Holmqvist; Gunnar Adell; Gunnar Arbman; Hong Zhang; Zong-Guang Zhou; Xiao-Feng Sun
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.